Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT04992728
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Restricted Spectrum Magnetic Resonance Imagining — OTHERRestriction Spectrum Magnetic Resonance Imaging (RS-MRI), which uses magnetism instead of x-rays to build up a picture of the inside of the body. The scan is completely painless but can be rather noisy and requires the patient to lie very still inside the center of a large, doughnut-shaped magnet for approximately 30-60 minutes complete the imaging.
Study Details
This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.
Key Dates
- Start date
- Nov 2, 2021
- Status verified
- Feb 2025
- Primary completion
- Nov 1, 2025
- Completion
- Nov 1, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Male Prostate PatientsAdult male patients with fair to good performance status and who (1) have undergone an MRI of the prostate for suspected or known prostate cancer and/or (2) are planning to undergo radical prostatectomy for prostate cancer.
Primary Outcome Measure
Detection of grade group ≥2 prostate cancer on histopathology [ Time Frame: 30 days ]
Central Contacts
- Gerald Henderson, BA858-534-4811
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCSD Moores Cancer Center | La Jolla | California | 92093 |
Find similar trials in La Jolla, CA
By condition
By specialty
By research site
Related Studies
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- SBRT Boost for Unfavorable Prostate Cancer'Recruiting · MemorialCare Health System · Fountain Valley, California
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerEARLY_PHASE1 · Recruiting · Ivan de Kouchkovsky, MD · San Francisco, California
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska